In this issue:
Antipsychotics and breast cancer risk in women with schizophrenia
Prenatal care and adverse pregnancy outcomes among women with schizophrenia
Probability of transition to psychosis in individuals at clinical high risk
Development over time of the population-attributable risk fraction for cannabis use disorder in schizophrenia
PANSS individual item and Marder dimension analyses from a trial of monthly extended-release risperidone in schizophrenia patients
Real-world outcomes and costs of LAI aripiprazole lauroxil for schizophrenia
rTMS and tDCS for auditory hallucinations in schizophrenia
OLZ/SAM for treatment of schizophrenia or bipolar I disorder
Effects of IPS + CR in early psychosis
Antipsychotic treatment strategies for acute phase and treatment resistance in schizophrenia
Please login below to download this issue (PDF)